Table 1.

Participant characteristics (N=2,358). Unadjusted mean (SD) or N (%).

Characteristic	No Cancer (n=691)	Cancer (n=1,667)	Gleason 8+ PCa (n=370)	Aggressive PCa (n=543)	Death due to PCa (n=93)	Non-Aggressive PCa (n=1,011)
Demographic/Clinical Characteristics
Age at Diagnosis	--	73.0 (7.6)	75.5 (8.0)	74.1 (8.2)	75.1 (7.9)	72.2 (7.2)
Birth Year	1931 (7.0)	1933 (7.8)	1931 (7.4)	1933 (7.8)	1929 (7.1)	1934 (7.7)
Blood Draw Year	2002 (2.3)	2002 (2.4)	2002 (2.3)	2002 (2.3)	2001 (2.4)	2002 (2.4)
Age at Blood Draw	71.6 (6.6)	68.9 (7.5)	71.1 (7.3)	69.9 (7.6)	71.9 (6.9)	68.3 (7.5)
BMI at Blood Draw	26.4 (4.2)	26.5 (4.0)	26.5 (3.9)	26.7 (4.0)	26.6 (4.0)	26.5 (4.0)
Area
Hawaii	331 (48)	836 (50)	220 (59)	296 (55)	27 (29)	510 (50)
Los Angeles	360 (52)	831 (50)	150 (41)	247 (45)	66 (71)	501 (50)
Ethnicity
Japanese	218 (32)	539 (32)	144 (39)	184 (34)	11 (12)	333 (33)
African American	156 (23)	363 (22)	64 (17)	108 (20)	37 (40)	216 (21)
Latino	153 (22)	347 (21)	53 (14)	97 (18)	24 (26)	214 (21)
White	131 (19)	325 (19)	84 (23)	118 (22)	20 (22)	192 (19)
Native Hawaiian	33 (5)	93 (6)	25 (7)	36 (7)	1 (1)	56 (6)
Tumor Characteristics
Gleason Score
≤7	--	1,231 (74)	0	145 (27)	35 (38)	1,011 (100)
≥8	--	370 (22)	370 (100)	370 (68)	42 (45)	0
NA	691 (100)	66 (4)	0	28 (5)	16 (17)	0
Stage
Localized	--	1,308 (78)	252 (68)	279 (51)	39 (42)	1,011 (100)
Regional	--	153 (9)	49 (13)	153 (28)	8 (9)	0
Metastatic	--	79 (5)	43 (12)	79 (15)	38 (41)	0
NA	691 (100)	127 (8)	26 (7)	32 (6)	8 (9)	0
4K Markers
Total PSA (ng/mL)	4.60 (4.94)	7.58 (16.15)	10.23 (23.74)	10.32 (22.73)	21.49 (38.16)	5.62 (5.56)
Free PSA (ng/mL)	1.13 (0.88)	1.31 (3.16)	1.74 (6.05)	1.72 (5.30)	3.65 (9.04)	1.07 (0.84)
Intact PSA (ng/mL)	0.55 (0.43)	0.74 (2.21)	1.06 (4.25)	1.05 (3.75)	2.47 (6.66)	0.57 (0.50)
hK2 (ng/mL)	0.09 (0.14)	0.11 (0.18)	0.15 (0.29)	0.15 (0.28)	0.29 (0.43)	0.10 (0.10)
4K Score (%)	15.3 (15.5)	27.5 (24.2)	35.7 (26.9)	34.7 (27.3)	50.1 (32.5)	24.7 (21.1)